NHS National Framework Agreement for the Supply of Recombinant Von Willebrand Factor

A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)

Source
OJEU
Type
Framework (Supply)
Duration
5 month (est.)
Value
£2M
Sector
HEALTH
Published
01 Feb 2021
Delivery
01 Feb 2021 to 30 Jun 2021 (est.)
Deadline
n/a

Concepts

Location

ITT lists purchasing points. Framework intended for use by the NHS in England, the Department of Health and Social Care and Public Health England. The framework may also be used by private sector contractors working on behalf of the above.

Geochart for 2 buyers and 1 suppliers

2 buyers

1 supplier

Description

NHS National Framework Agreement for the supply of Recombinant Von Willebrand Factor. The framework will commence on 1 February 2021 for a period of 5 months, with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 43 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the invitation to offer documents for the list of purchasing points.

Award Detail

1 Shire Pharmaceuticals (London)
  • Num offers: 1
  • Value: £1

Award Criteria

Security of supply 20.0
Ease of use 15.0
PRICE 65.0

CPV Codes

  • 33600000 - Pharmaceutical products
  • 33141530 - Blood coagulants

Indicators

  • Award on basis of price and quality.

Reference

Domains